These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36035038)

  • 21. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine.
    Qureshi MIA; Azam B; Waheed MA; Imran A
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.
    Katyal N; Narula N; Govindarajan R
    J Neuromuscul Dis; 2021; 8(2):287-294. PubMed ID: 33325394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets.
    Paz ML; Barrantes FJ
    ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
    Kupersmith MJ
    J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis.
    Mustafa MS; Marshal M; Ahern E; Crowley P
    Eur J Case Rep Intern Med; 2018; 5(2):000785. PubMed ID: 30756011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient.
    Huber M; Rogozinski S; Puppe W; Framme C; Höglinger G; Hufendiek K; Wegner F
    Front Neurol; 2020; 11():576153. PubMed ID: 33123081
    [No Abstract]   [Full Text] [Related]  

  • 30. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures.
    Yoo YJ; Han SB; Yang HK; Hwang JM
    Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis.
    Pourmand R
    Dis Mon; 1997 Feb; 43(2):65-109. PubMed ID: 9118787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi G; Lippi G
    Clin Chem Lab Med; 2022 May; 60(6):930-933. PubMed ID: 35303764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection.
    Essajee F; Lishman J; Solomons R; Abraham DR; Goussard P; Van Toorn R
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34380685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Juvenile myasthenia gravis in sub-Saharan Africa: a case study of two consanguine sisters born from consanguinity in Togo].
    Maneh N; Apetse K; Diatewa BM; Domingo SA; Agba AI; Ayena KD; Balogou KA; Balo KP
    Pan Afr Med J; 2017; 28():63. PubMed ID: 29230265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.
    Farid E; Herrera-Uribe J; Stevenson NJ
    Front Immunol; 2022; 13():817597. PubMed ID: 35711448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudopartial Third Nerve Palsy as the Presenting Sign of Ocular Myasthenia Gravis.
    Bertolet AN; Druckenbrod RC
    Optom Vis Sci; 2020 May; 97(5):377-382. PubMed ID: 32413010
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.